Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Doxorubicin Induction with High-Dose Chemotherapy and Stem Cell Support for Metastatic Breast Cancer
NCT00004906Phase 2Completed
- Sponsor
- Hackensack Meridian Health
- Start
- Oct 1999
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, doxorubicin in breast cancer, sponsored by Hackensack Meridian Health. Started Oct 1999; status: completed.
02
Drugs
docetaxeldoxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00004906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004906.